Patents by Inventor Rasmus Mose

Rasmus Mose has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for manufacturing 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine
    Patent number: 9637468
    Abstract: The invention discloses improved processes for manufacturing a compound, 5-(2,6-Di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine, its monohydrochloride salt and intermediates thereof.
    Type: Grant
    Filed: October 21, 2013
    Date of Patent: May 2, 2017
    Assignee: Novartis AG
    Inventors: Dietmar Flubacher, Nicole Bieri, Murat Acemoglu, Pascal Michel, Rasmus Mose, Hans Stettler, Maria Caterina Testa, Joerg Brozio, Frank Schaefer
  • Manufacturing process for pyrimidine derivatives
    Patent number: 9452994
    Abstract: The invention relates to processes for manufacturing a compound of formula 5, or a stereoisomer, tautomer or a salt thereof, wherein the substituents are as defined in the specification. The invention further relates to new manufacturing processes for specific solid forms of Compound A and its salts, to such solid forms and to use of such solid forms for the therapeutic treatment of warm-blooded animals.
    Type: Grant
    Filed: May 6, 2016
    Date of Patent: September 27, 2016
    Assignee: Novartis AG
    Inventors: Dietmar Flubacher, Pascal Michel, Maria Caterina Testa, Rasmus Mose
  • MANUFACTURING PROCESS FOR PYRIMIDINE DERIVATIVES
    Publication number: 20160251334
    Abstract: The invention relates to processes for manufacturing a compound of formula 5, or a stereoisomer, tautomer or a salt thereof, wherein the substituents are as defined in the specification. The invention further relates to new manufacturing processes for specific solid forms of Compound A and its salts, to such solid forms and to use of such solid forms for the therapeutic treatment of warm-blooded animals.
    Type: Application
    Filed: May 6, 2016
    Publication date: September 1, 2016
    Inventors: Dietmar Flubacher, Pascal Michel, Maria Caterina Testa, Rasmus Mose
  • Process for Manufacturing 5-(2,6-Di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine
    Publication number: 20150246897
    Abstract: The invention discloses improved processes for manufacturing a compound, 5-(2,6-Di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine, its monohydrochloride salt and intermediates thereof.
    Type: Application
    Filed: October 21, 2013
    Publication date: September 3, 2015
    Inventors: Dietmar FLUBACHER, Nicole BIERI, Murat ACEMOGLU, Pascal MICHEL, Rasmus MOSE, Hans STETTLER, Caterina Maria TESTA, Jörg BROZIO, Frank SCHAEFER
  • MANUFACTURING PROCESS FOR PYRIMIDINE DERIVATIVES
    Publication number: 20150232446
    Abstract: The invention relates to processes for manufacturing a compound of formula 5, or a stereoisomer, tautomer or a salt thereof, wherein the substituents are as defined in the specification. The invention further relates to new manufacturing processes for specific solid forms of Compound A and its salts, to such solid forms and to use of such solid forms for the therapeutic treatment of warm-blooded animals.
    Type: Application
    Filed: May 6, 2015
    Publication date: August 20, 2015
    Inventors: John Vincent Calienni, Dietmar Flubacher, Baoqing Gong, Prasad Kapa, Hui Liu, Pascal Michel, Rasmus Mose, Maria Caterina Testa
  • MANUFACTURING PROCESS FOR PYRIMIDINE DERIVATIVES
    Publication number: 20130225571
    Abstract: The invention relates to new crystalline forms of processes for manufacturing a compound of formula 5, or a stereoisomer, tautomer or a salt thereof, wherein the substituents are as defined in the specification. The invention further relates to new manufacturing processes for specific solid forms of Compound A and its salts, to such solid forms and to use of said solid forms for the therapeutic treatment of warm-blooded animals.
    Type: Application
    Filed: September 29, 2011
    Publication date: August 29, 2013
    Applicant: NOVARTIS AG
    Inventors: John Vincent Calienni, Marilyn De La Cruz, Dietmar Flubacher, Baoqing Gong, Prasad Koteswara Kapa, Piotr H. Karpinski, Hui Liu, Pascal Michel, Rasmus Mose, Maria Caterina Testa, Liladhar Murlidhar Waykole